Some of the biotech stocks making significant moves in Wednesday's pre-market are as follows (as of 8.15 A.M. ET).
In the Green
Black Diamond Therapeutics, Inc. (BDTX) is up over 50% at $2.49.CARGO Therapeutics, Inc. (CRGX) is up over 19% at $4.53.Ekso Bionics Holdings, Inc. (EKSO) is up over 16% at $0.50.biote Corp. (BTMD) is up over 11% at $4.55.Indaptus Therapeutics Inc (INDP) is up over 9% at $0.89.Milestone Scientific Inc. (MLSS) is up over 9% at $1.20.Lineage Cell Therapeutics, Inc. (LCTX) is up over 8% at $0.52.BioXcel Therapeutics Inc(BTAI) is up over 8% at $2.38.Lyell Immunopharma Inc (LYEL) is up over 7% at $0.52.CNS Pharmaceuticals Inc (CNSP) is up over 7% at $3.83.Wave Life Sciences Ltd (WVE) is up over 7% at $10.50.Caribou Biosciences, Inc. (CRBU) is up over 6% at $1.01Mobile-health Network Solutions (MNDR)is up over 5% at $2.32.Harvard Bioscience, Inc. (HBIO) is up over 5% at $0.71.Aethlon Medical Inc (AEMD) is up over 10% at $0.43.Semler Scientific, Inc. (SMLR) is up over 9% at $38.80.NextCure, Inc. (NXTC)is up over 6% at $0.62.Syra Health Corp. (SYRA) is up over 5% at Trevi Therapeutics Inc (TRVI) is up over 5% at $6.95.Beyond Air, Inc. (XAIR) is up over 5% at $0.30.Mobile-health Network Solutions (MNDR) is up over 5% at $2.32.Virpax Pharmaceuticals, Inc. (VRPX) is up over 5% at $0.14.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.